Pull to refresh
Logo
Daily Brief
Following Why Sign Up
Insurance-backed therapy platforms reshape how Americans access mental health care

Insurance-backed therapy platforms reshape how Americans access mental health care

New Capabilities

Grow Therapy's $3 billion valuation reflects a major industry shift as tech-enabled platforms replace the cash-pay therapy model with insurance-first coverage reaching hundreds of millions

March 3rd, 2026: Grow Therapy raises $150M Series D at $3 billion valuation

Overview

Updated May 30

For decades, finding a therapist who accepts insurance in the United States has been a contradiction: insurance plans technically cover mental health, but so few therapists participate in insurance networks that most patients either pay out of pocket or go without care. Grow Therapy, founded during the pandemic's mental health surge, has built an infrastructure layer that makes it easier for independent therapists to accept insurance—and it just raised $150 million at a $3 billion valuation, with roughly $1 billion in revenue and a network covering 220 million insured Americans.

Grow and competitors like Headway and Alma aren't therapy apps—they're insurance plumbing companies handling credentialing, billing, and claims so independent therapists can join insurance networks without drowning in paperwork.

Grow's new employer benefit, launching in March 2026, tackles another long-standing gap: when employees exhaust their limited Employee Assistance Program sessions, they lose their therapist and start over. Grow's system lets them keep the same provider and shift to insurance coverage. The question is whether these platforms can sustain growth as insurers push back on reimbursement rates and the market consolidates.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

$1B
Approximate annual revenue
Grow Therapy's reported revenue, up from pre-revenue in 2021
220M
Insured lives covered
Americans who can access Grow Therapy providers through their health plan
7M
Therapy visits facilitated in 2025
Sessions delivered through Grow's platform, up from 3 million at its Series C
$3B
Post-money valuation
More than doubled from $1.4 billion at Series C in April 2025
125+
Health plan partnerships
Including Medicaid and Medicare, up from 75 at time of Series C

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

Sign up to generate historical perspectives on this story.

Log in Sign Up

People Involved

Jake Cooper
Jake Cooper
Chief Executive Officer and Co-Founder, Grow Therapy
Leading Series D expansion into employer benefits and health system partnerships

Organizations Involved

Grow Therapy
Grow Therapy
Digital Health Platform
Expanding into employer benefits and health system integration after Series D

A technology platform that handles insurance credentialing, billing, and scheduling for independent mental health providers, enabling them to accept insurance patients without the administrative burden that drives most therapists to cash-only practice.
Headway
Headway
Digital Health Platform
Primary competitor with 50,000 providers and $2.3B valuation

A competing insurance-infrastructure platform for therapists, valued at $2.3 billion after a $100 million Series D in July 2024, with 50,000 providers across 50 states and expanding into Medicare Advantage and Medicaid.
TCV
TCV
Venture Capital / Growth Equity Firm
Co-led Grow Therapy's $150M Series D round

A growth equity firm that co-led Grow Therapy's Series D alongside Goldman Sachs Growth Equity, signaling institutional confidence in the insurance-backed therapy model.

Timeline

October 2008 March 2026

10 events Latest: March 3rd, 2026 · 6 months ago
Tap a bar to jump to that date

  1. Grow Therapy raises $150M Series D at $3 billion valuation

    Latest Funding

    Led by TCV and Goldman Sachs Growth Equity with new investors BCI and Menlo Ventures, the round valued Grow at $3 billion. The company reported roughly $1 billion in revenue, 7 million visits in 2025, and partnerships with 125+ health plans covering 220 million lives. The company simultaneously launched an integrated employer mental health benefit bridging Employee Assistance Programs and insurance-covered therapy.

  2. Alma acquired by Thoma Bravo

    Market

    Competitor Alma, backed by Optum Ventures and Cigna Ventures, was acquired by private equity firm Thoma Bravo, consolidating the insurance-infrastructure therapy market to fewer independent players.

  3. Grow Therapy raises $88M Series C at $1.4 billion valuation

    Funding

    Led by Sequoia Capital, the round valued Grow at $1.4 billion and funded the development of measurement-informed care and AI-assisted clinical tools. The company had facilitated 3 million therapy sessions at this point.

  4. Medicare begins reimbursing certain digital mental health treatments

    Regulation

    The Centers for Medicare and Medicaid Services started reimbursing FDA-authorized digital mental health treatments, expanding the addressable market for platforms operating within insurance networks.

  5. Competitor Headway raises $100M at $2.3 billion valuation

    Funding

    Headway's Series D, led by Spark Capital, more than doubled its valuation and signaled strong investor demand for insurance-infrastructure therapy platforms.

  6. BetterHelp parent Teladoc takes $790M impairment charge

    Market

    Teladoc Health withdrew its 2024 financial outlook as its direct-to-consumer therapy brand BetterHelp lost subscribers, highlighting the divergence between cash-pay and insurance-backed models.

  7. Grow Therapy raises $75 million Series B

    Funding

    The round expanded the provider network and insurance plan partnerships, establishing Grow as a significant player alongside Headway and Alma.

  8. Grow Therapy raises Series A

    Funding

    The company secured its first major institutional funding round, establishing its insurance-credentialing platform model.

  9. Grow Therapy founded during early pandemic

    Company

    Jake Cooper, Alan Ni, and Manoj Kanagaraj founded Grow Therapy to solve the structural gap between insurance coverage mandates and actual therapist participation in insurance networks, as pandemic-era demand for mental health services surged.

  10. Mental Health Parity and Addiction Equity Act signed into law

    Regulation

    The Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act required insurers to cover mental health on equal terms with physical health, affecting 140 million people. In practice, enforcement gaps meant most therapists still avoided insurance networks.

Scenarios

1

Insurance-infrastructure platforms become default path to therapy

Likely

Discussed by: Behavioral Health Business, Sequoia Capital investment thesis, healthcare venture analysts

Grow and Headway continue expanding insurance partnerships and provider networks until the majority of Americans seeking therapy default to these platforms rather than searching independently. With 220 million lives already covered and Medicare/Medicaid expansion underway, these platforms could become as embedded in mental health as electronic health records became in primary care. The employer benefit launch accelerates adoption by making Grow the single point of contact for companies replacing fragmented Employee Assistance Programs.

2

Reimbursement pressure squeezes platform margins, forcing consolidation

Possible

Discussed by: ClearHealthCosts investigation, therapist advocacy groups, healthcare industry analysts

Insurers like UnitedHealth's Optum have already begun cutting reimbursement rates for therapy sessions on competing platforms, with some contracts reportedly yielding zero margin per session. If insurers use their leverage to drive rates below sustainable levels, platforms face a choice between subsidizing sessions to maintain network size or losing providers. This could trigger consolidation—Alma's acquisition by Thoma Bravo in January 2026 may be an early signal—or force platforms to shift revenue models toward employer contracts and value-based care arrangements.

3

Provider backlash fragments the platform model

Possible

Discussed by: ClearHealthCosts, therapist forums, independent practice advocates

Therapists have already expressed frustration with platforms like Alma and Headway over delayed payments, administrative burdens, and declining reimbursement rates. If Grow's growth comes at the cost of provider satisfaction—lower effective pay, more administrative requirements, or AI-documentation mandates—therapists could leave for direct-pay models or unionize for better terms. The platform model depends on provider participation; a significant exodus would undermine the coverage numbers that attract insurers and employers.

4

Grow Therapy pursues an initial public offering

Possible

Discussed by: Bloomberg, PitchBook, growth equity analysts

With $1 billion in revenue, a $3 billion valuation, and blue-chip investors including Sequoia, Goldman Sachs, and TCV, Grow fits the profile of a late-stage health tech company approaching public markets. An IPO would test whether public investors value insurance-infrastructure platforms differently from the direct-to-consumer therapy companies that have struggled (Teladoc's market cap collapsed from $38 billion to under $3 billion). Grow's insurance-based revenue model and employer contracts could present a more durable growth story than advertising-dependent competitors.

Historical Context

3 moments from history that rhyme with this story — and how they unfolded.

2007–2019

Athenahealth and the billing-infrastructure model for physicians (2007–2019)

Athenahealth, founded by Jonathan Bush, built a cloud-based platform that handled insurance billing, claims processing, and practice management for physicians—the same administrative burden that kept doctors from focusing on patient care. The company went public in 2007 and grew to serve over 160,000 providers before being taken private by Veritas Capital and Elliott Management in 2019 for $5.7 billion.

Then

Athenahealth proved that a platform handling insurance paperwork for independent practitioners could become a multi-billion-dollar business.

Now

The model demonstrated that administrative infrastructure, not clinical delivery, was where technology companies could capture the most value in fragmented healthcare markets.

Why this matters now

Grow Therapy is applying the Athenahealth model specifically to mental health, where the gap between insurance coverage mandates and actual provider participation is even wider. The comparison suggests a potential outcome: durable infrastructure value, but eventual pressure from the same insurers whose complexity created the need.

October 2008

Mental Health Parity and Addiction Equity Act (2008)

Congress passed the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act, requiring insurers to cover mental health and substance use treatment on equal terms with physical health care. The law applied to roughly 140 million Americans in employer-sponsored plans. Enforcement fell to a patchwork of federal agencies, and the burden of filing complaints rested on individual consumers.

Then

Insurers complied on paper but maintained narrow provider networks and burdensome authorization processes that limited real access.

Now

Nearly two decades later, one in four insured Americans still cannot find an in-network mental health provider, and only 36% of psychiatrists accept new Medicaid patients. The law created the legal obligation; platforms like Grow are building the infrastructure to fulfill it.

Why this matters now

Grow Therapy's business exists in the gap between what the parity law requires and what insurers actually deliver. The company's core value proposition—making it easy for therapists to join insurance networks—directly addresses the enforcement failure that has persisted since 2008.

2013–2024

BetterHelp and the direct-to-consumer therapy boom (2013–2024)

BetterHelp, acquired by Teladoc Health in 2015, grew rapidly during the pandemic as millions signed up for subscription-based online therapy at roughly $300 per month out of pocket. Teladoc valued BetterHelp at billions. By mid-2024, BetterHelp was losing subscribers, and Teladoc took a $790 million impairment charge as consumers proved unwilling to sustain cash-pay therapy costs long-term.

Then

BetterHelp proved massive demand for accessible therapy existed but could not retain subscribers at cash-pay prices.

Now

The collapse validated the thesis that sustainable mental health platforms need to work through insurance, not around it. Grow and Headway's insurance-first model emerged as the counter-narrative.

Why this matters now

Grow Therapy's $3 billion valuation is explicitly a bet against the BetterHelp model. Where BetterHelp charged consumers directly and saw churn spike, Grow routes payment through insurers who already owe coverage under parity laws. The question is whether insurance reimbursement is more durable than consumer subscriptions.

Sources

(12)
+6
Bloomberg PR Newswire Behavioral Health Business MedCity News Tech Funding News Fierce Healthcare Grow Therapy Blog Healthcare Dive ClearHealthCosts Centers for Medicare and Medicaid Services Grow Therapy Blog PR Newswire